Trump’s new tariffs took effect at midnight. A selloff of U.S. treasuries is underway. China levies 84% tariff on U.S. goods.

With the recently announced layoffs of 3,500 FDA staffers and exits of branch directors Patrizia Cavazzoni and Peter Marks, ...

British drug maker GlaxoSmithKline has said it is giving up one of the Chinese patents on its popular diabetes drug Avandia following a challenge by 3 Chinese competitors. However, the decision won't ...

Pfizer has disappointed investors for the past three years, but its low valuation could make it attractive now. Its sales may decline a bit in 2025, but management has been targeting long-term ...

The gold (XAU/USD) price gained 0.44% on Wednesday, fuelled by the prospect of Federal Reserve (Fed) rate cuts and safe-haven buying due to trade tariffs uncertainty and geopolitical instability.

Bengaluru: Pfizer will divest its remaining stake in Haleon, marking its complete exit from the British consumer healthcare group. As part of the transaction, Haleon, known for household brands like ...

In an attempt to strike a pitch-perfect tone with Generation X, Pfizer has recruited Elizabeth Banks as the face of a new awareness campaign for pneumococcal pneumonia vaccination. Toward the end ...

Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors ...

With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. After charting similar ...

Drugmaker Pfizer has sold its entire stake in Haleon for about £2.5 billion to institutional investors and the consumer healthcare firm at 385 pence per share, a bookrunner for the deal said today.

Investing.com -- Oppenheimer has downgraded several bank stocks, including Cohen & Company, Goldman Sachs, and Jefferies, to Perform in a note Wednesday due to concerns about a delayed or ...

(Bloomberg) -- Pfizer Inc. raised about £2.55 billion ($3.3 billion) through the sale of its remaining 7.3% stake in Haleon Plc, culminating a years-long separation from the maker of Sensodyne ...